ArticleAnnals of clinical and translational neurology2026

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4-IgG-Positive NMOSD.

Jie Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.